15-43203127-G-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001114134.2(EPB42):c.1767C>A(p.His589Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,614,102 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001114134.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EPB42 | NM_001114134.2 | c.1767C>A | p.His589Gln | missense_variant | 11/13 | ENST00000441366.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EPB42 | ENST00000441366.7 | c.1767C>A | p.His589Gln | missense_variant | 11/13 | 1 | NM_001114134.2 | P1 | |
EPB42 | ENST00000567019.2 | n.1273C>A | non_coding_transcript_exon_variant | 6/8 | 1 | ||||
EPB42 | ENST00000648595.1 | c.1857C>A | p.His619Gln | missense_variant | 11/13 | ||||
EPB42 | ENST00000540029.5 | c.1533C>A | p.His511Gln | missense_variant | 10/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00570 AC: 867AN: 152120Hom.: 11 Cov.: 31
GnomAD3 exomes AF: 0.00130 AC: 327AN: 251492Hom.: 5 AF XY: 0.000993 AC XY: 135AN XY: 135922
GnomAD4 exome AF: 0.000538 AC: 787AN: 1461864Hom.: 9 Cov.: 32 AF XY: 0.000451 AC XY: 328AN XY: 727236
GnomAD4 genome AF: 0.00571 AC: 869AN: 152238Hom.: 11 Cov.: 31 AF XY: 0.00529 AC XY: 394AN XY: 74434
ClinVar
Submissions by phenotype
Hereditary spherocytosis type 5 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at